| Gene symbol | MET | Synonyms | AUTS9, DA11, DFNB97, HGFR, RCCP2, c-Met | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q31.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | MET proto-oncogene, receptor tyrosine kinase | ||||
| Gene symbol | CD274 | Synonyms | B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, hPD-L1 | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9p24.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD274 molecule | ||||
| GTO ID | GTC1972 |
| Trial ID | NCT03672305 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | c-MET|PD-L1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | c-Met/PD-L1 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC |
| Year | 2018 |
| Country | China |
| Company sponsor | The Second Hospital of Nanjing Medical University |
| Other ID(s) | JGZNO1 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||